Centaur Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Mumbai, Maharashtra, India, established in 1980.

1980 Mumbai, Maharashtra, India Active

Last Updated: January 06, 2026

About Centaur Pharmaceuticals Private Limited

Centaur Pharmaceuticals Private Limited, a active private limited company, was established on 15 October 1980 in Mumbai, Maharashtra, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: U24230MH1980PTC023291. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹20.00 Cr and a paid-up capital of ₹18.50 Cr.

Formerly known as Centaur Pharmaceuticals Limited. It upholds a compliant status. Employing 3,274 professional, Its leadership includes Rakhi Shridhar Kadam (Whole-Time Director), Shivanand Dattatraya Sawant (Managing Director), Sharadchandra Damodar Abhyankar (Director). Past directors included Rakhi Shridhar Kadam, Sajit Kumar, Prabhakar Mahadeo Thakoor. It holds ₹308.00 Cr open charges and ₹239.90 Cr settled loans. Its latest AGM occurred on 13 August 2025, with the balance sheet filed on 31 March 2025. It is based at Centaur House, Shanti Nagar, Vakola, Santacruz (E),, Mumbai, Maharashtra, 400055.

Company Details

CIN/LLPIN
U24230MH1980PTC023291
Registration Number
023291
Incorporation Date
15 October 1980
Authorized Capital
₹20.00 Cr
Paid-Up Capital
₹18.50 Cr
ROC Code
Roc Mumbai
Listing Status
Unlisted
Company Status
Active

Key Metrics

Authorised Capital ₹ 20.00 Cr as on 06-01-2026
Paid Up Capital ₹ 18.50 Cr as on 06-01-2026
Company Age 45 Year, 4 Months
Last Filing with ROC 31 Mar 2025
Open Charges ₹ 308.00 Cr as on 06-01-2026
Satisfied Charges ₹ 239.90 Cr as on 06-01-2026
Revenue Growth **** -6.18% (FY 2023)
Profit Growth **** -42.94% (FY 2023)
Ebitda **** -40.72% (FY 2023)
Net Worth 12.37% (FY 2023)
Total Assets **** 5.84% (FY 2023)

Comprehensive Company Insights

Explore comprehensive insights into Centaur Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Centaur Pharmaceuticals Private Limited?

Current Directors

Name	Designation	Appointment Date	Status
Rakhi Shridhar Kadam	Whole-Time Director	14 Sep 2015	Current
Shivanand Dattatraya Sawant	Managing Director	15 Oct 1980	Current
Sharadchandra Damodar Abhyankar	Director	11 Aug 2016	Current
Supriya Samar Desai	Whole-Time Director	21 Dec 2021	Current
Albert Taura	Director	11 Aug 2016	Current
Smita Abhayakumar Phal	Whole-Time Director	22 Jun 2011	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Additional Director	24 Mar 2015	Past
Pramod Abcsdd	Nominee Director	03 Apr 2014	Past
Pramod Abcsdd	Director	23 Oct 2008	Past
Pramod Abcsdd	Director	08 Jun 2015	Past
Pramod Abcsdd	Nominee Director	21 Apr 2011	Past
Pramod Abcsdd	Additional Director	25 Aug 2022	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Centaur Pharmaceuticals.

Centaur Pharmaceuticals Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 6.18% decrease. The company also saw a substantial fall in profitability, with a 42.94% decrease in profit. The company's net worth Soared by an impressive increase of 12.37%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

-6.18%

*******

Revenue from Operations

*******

-6.67%

*******

Total Assets

*******

5.84%

*******

Profit or Loss

*******

-42.94%

*******

Net Worth

*******

12.37%

*******

EBITDA

*******

-40.72%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Centaur Pharmaceuticals?

In 2024, Centaur Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹3,080,000,000.00

Satisfied Charges

₹2,399,020,215.00

Charges Breakdown by Lending Institutions

State Bank Of India : 308.00 Cr

Latest Charge Details

Date	Lender	Amount	Status
03 May 2011	State Bank Of India	₹154.00 Cr	Open
03 Aug 2006	State Bank Of India	₹154.00 Cr	Open
26 May 2015	Tata Capital Financial Services Limited	₹1.70 Cr	Satisfied
27 Jan 2015	Tata Capital Financial Services Limited	₹3.00 Cr	Satisfied
19 May 2014	Tata Capital Financial Services Limited	₹12.50 Cr	Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Centaur Pharmaceuticals?

Centaur Pharmaceuticals has a workforce of 3274 employees as of Oct 11, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Centaur Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Centaur Pharmaceuticals's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Centaur Pharmaceuticals

Recent Activity within the Organization

Annual General Meeting

The activity Centaur Pharmaceuticals Private Limited last Annual general meeting of members was held on 13 Aug 2025 as per latest MCA records. was completed.
13 Aug 2025
Balance Sheet

Progress on Centaur Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was documented.
31 Mar 2025
Director Appointment

Progress on Supriya Samar Desai was appointed as a Whole-time director was appointed as a Whole-time director on 21 Dec 2021 & has been associated with this company since 4 years 2 months . was documented.
21 Dec 2021
Charges

Progress on A charge with State Bank Of India of Rs. 154.00 Cr registered on 03 Aug 2006 with Charge ID 10015268 was modified on 28 Oct 2020. was documented.
28 Oct 2020
Charges

A charge with State Bank Of India of Rs. 154.00 Cr registered on 03 May 2011 with Charge ID 10291402 was modified on 24 Feb 2020. was recorded as a recent event.
24 Feb 2020
Director Appointment

Sharadchandra Damodar Abhyankar was appointed as a Director was appointed as a Director on 11 Aug 2016 & has been associated with this company since 9 years 6 months . was recorded as a recent event.
11 Aug 2016

Explore recent activity and updates - View Recent Activity